Plasma carnitine ester profiles in Crohn's disease and ulcerative colitis patients with different IGR2230a-1 genotypes

International Journal of Immunogenetics

Volumn 36, Issue 6, 2009, Pages 329-335

  Talian G ^a   Lakner, L ^b   Bene, J ^a   Komlosi K ^a   Horvath K ^a   Gasztonyi, B ^c   Miheller, P ^d   Figler, M ^a   Mozsik G ^a   Tulassay, Z ^d,e   Melegh, B ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Markusovszky Teaching Hospital   (Hungary)

^c Zala County Hospital   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; PRESTIN; ESTER; ORGANIC CATION TRANSPORTER; SLC22A5 PROTEIN, HUMAN;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUNGARY; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; HOMOZYGOTE; METHODOLOGY; MIDDLE AGED;

ADULT; CARNITINE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ESTERS; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 75549090276     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00834.x     Document Type: Article

References (44)

1. Adlouni, H.A., Katrib, K. & Ferard, G. (1988) Changes in carnitine in polymorphonuclear leukocytes, mononuclear cells, and plasma from patients with inflammatory disorders. Clinical Chemistry, 34,40.
2. Babusukumar, U., Wang, T., McGuire, E., Broeckel, U. & Kugatha- san, S. (2006) Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. The American Journal of Gastroenterology, 101,1354.
3. Bene, J., Komlosi, K., Havasi, V.,Talian, G., Gasztonyi, B., Horvath, K., Mozsik, G., Hunyady, B., Melegh, B. & Figer, M. (2006a) Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. World Journal of Gastroenterology, 12,110.
4. Bene, J., Magyari, L., Talian, G., Komlosi, K., Gasztonyi, B., Tari, B., Varkonyi, A., Mozsik, G. & Melegh, B. (2006b) Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World Journal of Gastroenterology, 12, 5550.
5. Bene, J., Komlosi, K., Magyari, L., Talian, G., Horvath, K., Gasztonyi, B. et al. (2007) Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. British Journal of Nutrition, 98,345.
6. Bieber, L.L. (1988) Carnitine. Annual Review of Biochemistry, 57, 261.
7. Brass, E.P. (2002) Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacological Reviews, 54, 589.
8. Cetinkaya, A., Bulbuloglu, E., Kantarceken, B., Ciralik, H., Kurutas, E.B., Buyukbese, M.A. & Gumusalan, Y. (2006) Effects of 1-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Digestive Diseases and Sciences, 51, 488.
9. Chace, D.H., Kalas, T.A. & Naylor, E.W. (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clinical Chemistry, 49,1797.
10. Costa, C.C., de Almeida, I.T., Jakobs, C., Poll-The, B.T. & Duran, M. (1999) Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatric Research, 46, 440.
11. Cummings, J.H., Rombeau, J.L. & Sakata, T. (1995) Physiological and Clinical Aspects of Short Chain Fatty Acids. Cambridge University Press, Cambridge, UK.
12. D'Argenio, G., Calvani, M., Casamassimi, A., Petillo, O., Margarucci, S., Rienzo, M. et al. (2006) Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes. FASEB Journal, 20, 2544.
13. Demirkol, M., Sewell, A.C. & Bohles, H. (1994) The variation of carnitine content in human blood cells during disease - a study in bacterial infection and inflammatory bowel disease. European Journal of Pediatrics, 153, 565
14. Gasbarrini, G., Mingrone, G., Giancaterini, A., De Gaetano, A., Scarfone, A., Capristo, E., Calvani, M., Caso, V. & Greco, A.V. (2003) Effects ofpropionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Hepatogastroenterology, 50,1385.
15. Giallourakis, C., Stoll, M., Miller, K., Hampe, J., Lander, E.S., Daly, M.J., Schreiber, S. & Rioux, J.D. (2003) IBD5 is ageneral risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. American Journal of Human Genetics, 73, 205
16. Grundemann, D., Harlfinger, S., Golz, S., Geerts, A., Lazar, A.,Berkels, R., Jung, N., Rubbert, A. & Schomig, E. (2005)
17. Discovery of the ergothioneine transporter. Proceedings of the National Academy of Sciences USA, 102, 5256.
18. Hamilton, J.W., Li, B.U., Shug, A.L. & Olsen, W.A. (1986) Carnitine transport in human intestinal biopsy specimens. Demonstration ofan active transport system. Gastroenterology, 91, 10.
19. Latiano, A., Palmieri, O., Valvano, R.M., D'Inca, R., Vecchi, M., Ferraris, A. et al. (2006) Contribution of IBD5 locus to clinical features of IBD patients. The American Journal of Gastroenterology, 101, 318.
20. Magyari, L., Bene, J., Komlosi, K., Talian, G., Farago, B.,Csongei, V. et al. (2007) Prevalence of SLC22A4, 1672Tand SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients. Pathology Oncology Research, 13, 53.
21. McGovern, D.P., van Heel, D.A., Negoro, K., Ahmad, T. & Jewell, .P. (2003) Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. American Journal of Human Genetics, 73, 1465.
22. Melegh, B., Kerner, J. & Bieber, L.L. (1987) Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochemical Pharmacology, 36, 3405.
23. Nezu, J., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N. et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nature Genetics, 21, 91.
24. Noble, C.L., Nimmo, E.R., Drummond, H., Ho, G.T., Tenesa, A., Smith, L., Anderson, N., Arnott, I.D. & Satsangi, J. (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology, 129, 1854.
25. Orholm, M., Munkholm, P., Langholz, E., Nielsen, O.H., Sorensen, T.I. & Binder, V. (1991) Familial occurrence of inflammatory bowel disease. The New England Journal ofMedicine, 324, 84.
26. Palmieri, O., Latiano, A., Valvano, R., D'Inca, R., Vecchi, M., Sturniolo, G.C. et al. (2006) Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics, 23,497.
27. Peltekova, V.D., Wintle, R.F., Rubin, L.A., Amos, C.I., Huang, Q., Gu, X. et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genetics, 36, 471.
28. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genetics, 29, 223.
29. Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., McLeod, R.S., Griffiths, A.M. et at. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. American Journal of Human Genetics, 66, 1863.
30. Roediger, W.E. (1980) The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet, 2,712.
31. Rogler, G. (2004) Update in inflammatory bowel disease pathogenesis. Current Opinions in Gastroenterology, 20, 311.
32. Russell, R.K., Drummond, H.E., Nimmo, E.R., Anderson, N.H., Noble, C.L., Wilson, D.C. et al. (2006) Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut, 55, 1114.
33. Schulze, A., Lindner, M., Kohlmuller, D., Olgemoller, K., Mayatepek, E. & Hoffmann, G.F. (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics, 111, 1399.
34. Silverberg, M.S. (2006) OCTNs: will the real IBD5 gene please stand up? World Journal of Gastroenterology, 12, 3678.
35. Silverberg, M.S., Duerr, R.H., Brant, S.R., Bromfield, G., Datta, L.W., Jani, N. et al. (2007) Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. European Journal of Human Genetics, 15, 328.
36. Srinivas, S.R., Prasad, P.D., Umapathy, N.S., Ganapathy, V. & Shekhawat, P.S. (2007) Transport ofbutyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+. American Journal of Physiology. Gastrointestinal and Liver Physiology, 293, G1046-G1053.
37. Steiber, A., Kerner, J. & Hoppel, C.L. (2004) Carnitine: a nutritional, biosynthetic, and functional perspective. Molecular Aspects of Medicine, 25, 455.
38. Torkvist, L., Noble, C.L., Lordal, M., Sjoqvist, U., Lindforss, U., Nimmo, E.R., Lofberg, R., Russell, R.K. & Satsangi, J. (2007) Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scandinavian Journal of Gastroenterology, 42, 200.
39. Tosa, M., Negoro, K., Kinouchi, Y., Abe, H., Nomura, E., Takagi, S. et al. (2006) Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scandinavian Journal ofGastroenterology, 41, 48.
40. Vaz, F.M. & Wanders, R.J. (2002) Carnitine biosynthesis in mammals. Biochemical Journal, 361, 417.
41. Vermeire, S., Pierik, M., Hlavaty, T., Claessens, G., van Schuerbeeck, N., Joossens, S. et al. (2005) Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology,129, 1845.
42. Vernia, P., Marcheggiano, A., Caprilli, R., Frieri, G., Corrao, G., Valpiani, D., Di Paolo, M.C., Paoluzi, P. & Torsoli, A. (1995) Short-chain fatty acid topical treatment in distal ulcerative colitis. Alimentary Pharmacology & Therapeutics, 9, 309
43. Waller, S., Tremelling, M., Bredin, F., Godfrey, L., Howson, J. & Parkes, M. (2006) Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut, 55, 809
44. Wu, X., Prasad, P.D., Leibach, F.H. & Ganapathy, V. (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochemical and Biophysical Research Communications, 246, 589.